Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XP19986 in Acute Back Spasms
NCT00817986Phase 2Completed
- Sponsor
- XenoPort, Inc.
- Start
- Dec 2008
- Primary completion
- Jul 2009
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arbaclofen placarbil in back muscle spasm, sponsored by XenoPort, Inc.. Started Dec 2008; status: completed.
02
Drugs
arbaclofen placarbil
03
Conditions
back muscle spasm
Beyond the preview
Go deeper on NCT00817986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00817986.